For over 200 years, New York Eye and Ear Infirmary of Mount Sinai (NYEE) has cared for those hoping to see, taught those seeking to learn, and inspired those yearning to discover. Founded in 1820 NYEE is America’s first specialty hospital. Combining a rich history of specialty care with award-winning clinical excellence, NYEE is committed to serving its community, as well as patients nationally and internationally.
Today, NYEE is one of the leading institutions for the treatment of complex ophthalmic disorders remaining at the forefront for innovative surgical specialty services. The institution serves as the clinical site for breakthrough translational research—introducing many novel diagnostic and surgical techniques—with a growing network of satellite practices across the New York metropolitan area. Our physicians are also passing the tradition of excellence onto future generations through a highly competitive residency program and dozens of post-graduate ophthalmology fellowship positions.
Novel MIGS stent technology boasts robust IOP-lowering effect in open-angle glaucomaOctober 2nd 2022
First-in-human biologic stent in ophthalmology is a conforming implant material, i.e., a soft, scleral wall compliant bio-tissue to structurally reinforce the cyclodialysis cleft opening.
High-tech imaging offers new way to detect early signs of glaucomaAugust 4th 2022
According to a new study from New York Eye and Ear Infirmary of Mount Sinai, a new, non-invasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss.
Eye stroke: Mount Sinai program stresses awareness and emergent care for sudden vision lossJuly 27th 2022
Gareth Lema, MD, PhD, discusses an innovative eye stroke program at Mount Sinai Health System that involves collaboration among ophthalmologists, the stroke service, and emergency department physicians.
RNA-Seq analysis identifies cell subtypes to use as models for corneal wound healingMay 12th 2022
At ARVO 2022 in Denver, Colorado, Timothy Blenkinsop, MD, presented “3D Eye Organoids with Distinct Cornea.” His presentation outlined how these organoids have developed sophisticated cornea structures.